Sign up
Pharma Capital

Q BioMed to present at 30th annual Roth Conference

The conference is being held at the Ritz Carlton hotel in Dana Point, California next week
conference room
CEO Denis Corin is presenting at the conference on Monday at 2pm

Biotech acceleration company Q BioMed Inc (OTCMKTS:QBIO) is to present at the 30th annual Roth Conference in California next week.

READ: OTC-listed cannabis companies heading to Roth Conference

Chief executive Denis Corin will give a presentation on Monday (March 12), while he will also be available for one-on-one investor meetings on Monday and Tuesday (March 13).

View full QBIO profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.